The dramatic stimulus-fueled rally in Chinese stocks has cost traders betting against US-listed shares roughly $6.9 billion in mark-to-market losses, according to a report from S3 Partners.

While not as dramatic as China’s abandonment of the zero-COVID policy in late 2022, the underlying reasons for the surprising ...

Alibaba's massive buyback program and AI potential enhance its appeal and offers a solid risk-reward. See more about BABA stock and why I'm neutral on it.

In the Melbourne CBD market hit hard by the pandemic, some office vendors hope high replacement costs make their existing ...